FRED ALGER MANAGEMENT, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 233 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
FRED ALGER MANAGEMENT, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2019$139,000
-73.6%
35,4470.0%0.00%
-50.0%
Q2 2019$527,000
-76.5%
35,447
-60.8%
0.00%
-77.8%
Q1 2019$2,244,000
+59.6%
90,411
+15.5%
0.01%
+50.0%
Q4 2018$1,406,000
-32.7%
78,296
+10.2%
0.01%
-25.0%
Q3 2018$2,088,000
-73.4%
71,078
-58.8%
0.01%
-75.8%
Q2 2018$7,837,000
+22.4%
172,356
+42.1%
0.03%
+10.0%
Q1 2018$6,405,000
-85.3%
121,302
-81.1%
0.03%
-84.8%
Q4 2017$43,704,000
-36.0%
642,709
-22.4%
0.20%
-38.2%
Q3 2017$68,261,000
+30.7%
828,407
+48.5%
0.32%
+28.1%
Q2 2017$52,216,000
+391.0%
557,680
+233.9%
0.25%
+369.8%
Q1 2017$10,635,000
+244.4%
167,035
+140.3%
0.05%
+211.8%
Q4 2016$3,088,000
+350.8%
69,508
+265.8%
0.02%
+325.0%
Q3 2016$685,000
-92.9%
19,000
-81.9%
0.00%
-92.5%
Q3 2015$9,655,000
-19.2%
104,991
-22.8%
0.05%
-1.9%
Q2 2015$11,954,000
+4.5%
136,024
-11.7%
0.05%
+3.8%
Q1 2015$11,440,000
+33547.1%
154,119
+25374.2%
0.05%
Q4 2014$34,000
+25.9%
6050.0%0.00%
Q3 2014$27,000
+8.0%
6050.0%0.00%
Q2 2014$25,000
-40.5%
6050.0%0.00%
Q1 2014$42,000
+16.7%
605
+2.5%
0.00%
Q4 2013$36,0000.0%5900.0%0.00%
Q3 2013$36,0005900.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2018
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$60,485,054,00053.20%
Palo Alto Investors LP 2,121,857$157,505,0007.79%
NEA Management Company, LLC 2,279,781$169,228,0007.65%
EcoR1 Capital, LLC 243,048$18,041,0006.01%
Redmile Group, LLC 900,879$66,872,0006.00%
Opaleye Management Inc. 140,000$10,392,0004.82%
PFM Health Sciences, LP 2,266,756$168,261,0004.64%
Partner Investment Management, L.P. 40,798$3,028,0004.56%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 826,919$61,383,0003.74%
Opus Point Partners Management, LLC 55,988$4,156,0003.48%
View complete list of CLOVIS ONCOLOGY INC shareholders